The U.S. is operating under the national emergency Proclamation 9994 concerning the COVID-19 pandemic and that this national emergency remains in effect until rescinded or terminated by the President of the U.S. Conditions are dynamic and related policies and guidance evolve accordingly. Refer to the materials below to learn more about how you should or may protect persons (whether vaccinated or unvaccinated) involved in any of your in-person research activities. See also the related Federal Register notice.
CURRENT UPDATE: Normal, pre-pandemic research that involve in-person activities with human research participants were permitted to resume on August 1, 2021, but restrictions apply (see Exceptions panel below). Refer to the other panels to access FSU IRB instructions and related resources, as well as general COVID-19 related resources provided by federal agencies.
The IRB has federal regulatory and FSU policy authority to impose conditions for approval of research in order to minimize risks (including COVID-19-related risks) to human subjects and others; these conditions are imposed pursuant to the IRB's authority in accordance with federal law at Title 45 of the U.S. Code of Federal Regulations, Part 46 (45 CFR 46), sections 46.109 and 46.111. Institutional officials are prohibited from approving of any study that is not approved by the IRB, including failure to satisfy the IRB conditions and requirements noted above (45 CFR 46, section 46.112).